ArticleHealth economics review2025
Wealth, health expenditure and cancer: an econometric analysis for European countries.
Article in Health economics review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe main purpose of this study is to examine the effects of health expenditures and wealth on cancer treatment success in European countries. Cervical cancer data were used for this purpose.
methodsCervical cancer incidence/death rate (CANCER), Gross Domestic Product per capita (GDPP) and Current health expenditure (HEXP) were included as predictors. Cancer data was obtained from WHO European Data Warehouse while health expenditure and wealth datas were obtained from World Bank Development Indicators. Panel regression models, panel ARDL cointegration analysis and Dumitrescu-Hurlin causality analysis were used to define the existence of a statistical relationship between variables.
resultsThe result obtained in the model shows the existence of a positive relationship between cervical cancer and all independent variables (health expenditures and wealth). While cervical cancer treatment success in the European countries is highly sensitive to health expenditure, the effect of wealth on cervical cancer is very weak. According to the findings of the causality analysis, a unidirectional causal relationship from HEXP to CANCER and a unidirectional causal relationship from GDPP to CANCER was determined in analysis. So, independent variables in the model are the cause of cervical cancer.
conclusionThis study provides important evidence for policy makers to allocate relevant and economic resources to healthcare services to succeed in cervical cancer. The determination that health expenditures have a positive effect on the treatment of cervical cancer provides a clue that more efforts should be made regarding the economic accessibility of health services in european countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.